Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.

about

A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease Gene therapeutics for periodontal regenerative medicine.Atlas-based functional radiosurgery: early results.Gene therapy in periodontics.

P2860

Q34209755-78ADDDAB-5311-4460-8596-A9C51B6FAC98 Q36418370-A2B9FB5E-65FF-4D4A-A154-14B8ED28A906 Q39306233-D0FE3660-159F-457B-BF1F-1C6C661E2166 Q41830129-66A546C6-0017-401A-A7FE-1950412969F2

P2860

Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.

Item

http://www.wikidata.org/entity/Q36150495

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.

@ast

Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.

@en

type

Item

label

Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.

@ast

Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.

@en

prefLabel

Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.

@ast

Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.

@en

P1476

Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.

@en

P2093

Hideo Tsukada

http://www.w3.org/2001/XMLSchema#string

Imaharu Nakano

http://www.w3.org/2001/XMLSchema#string

Keiya Ozawa

http://www.w3.org/2001/XMLSchema#string

Shin-ichi Muramatsu

http://www.w3.org/2001/XMLSchema#string

P2860

Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer

Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.

Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates.

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

Molecular biology of catecholamine-related enzymes in relation to Parkinson's disease.

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.

P304

663-671

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.5.5.663

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15934841

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

gene therapy

vector-borne disease

Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.

about

P2860

P2860

Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921